Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980, United States
Location status: Recruiting
Location contact
Clinical Trials Referral Office
CONTACT
Folakemi T. Odedina, Ph.D.
PRINCIPAL_INVESTIGATOR
Quincy Wimberly
CONTACT
NCT Number: NCT06541210
This clinical trial the possibility of establishing a Community Living Labs (CoLLab) Learning Health System to facilitate access to prostate health Risk, Education, and Assessment in the Community with Help (REACH) services in Black men and compares the impact to American Legion Posts with no CoLLab set up at the individual and community levels. Cancer is the second leading cause of death for Black men and Black men are less likely to receive prostate cancer screening. CoLLab Learning Health System utilizes community health workers (CHW) that are well-trained to form a bridge between communities and clinicians. In fact, Black men who work with CHW's typically have better access to health services, gain knowledge about cancer, cancer prevention, treatment and may have better overall health outcomes. Establishing a CoLLab Learning Health System at American Legion Posts may improve access to clinical trials and prostate cancer services in Black men.
Interested in participating?
Request Info21 year–80 year
All sexes
Interventional
Not applicable
Jacksonville, Florida, 32224-9980, United States
Location status: Recruiting
Clinical Trials Referral Office
CONTACT
Folakemi T. Odedina, Ph.D.
PRINCIPAL_INVESTIGATOR
Quincy Wimberly
CONTACT
PRIMARY OBJECTIVES:
I. Co-create real-life user centric CoLLab Learning Health System at three American Legion Posts, compared to an American Legion Post with no CoLLab set-up. American Legion Post 197 will serve as the hub and Post 244 and Post 194 as the spokes.
II. Assess and evaluate the impact of the CoLLab Learning Health Systems compared to the comparison Post at the individual and community levels.
III. Explore the feasibility of replicating the CoLLab Learning Health System in Black communities nationally.
OUTLINE:
Participants access CoLLab Learning Health System to use any of the services at least twice monthly for up to 1 year.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Access CoLLab Learning Health System to use any of the services
Other names: non-interventional study
Ancillary studies
Time frame: Up to 12 months
Qualitative data collection will be employed during a town hall meeting with the CoLLab Community Advisory Board (CAB) to ensure that we get unbiased and objective feedback from participants.
Time frame: Baseline; up to 12 months
Will be assessed using pre-test and post-test survey scores from a Prostate Health Resources Questionnaire, which consists of 6 multiple choice questions, 8 true/false/don't know questions, 13 questions answered on a 5-point scale (e.g., very favorable to unfavorable or strongly agree to strongly disagree), and 20 yes/no questions.
Time frame: Up to 24 months
Will be assessed using cost analysis of direct and indirect costs.
Time frame: Up to 24 months
Will be assessed qualitatively based on interviews of key personnel and users
Contact information is provided by the study sponsor or research team.
Clinical Trials Referral Office
CONTACT
Quincy Wimberly
CONTACT
Mayo Clinic
Other
Building Community Living Labs (CoLLab) in Black Communities With the Goal of Advancing Prostate Health Equity and Reducing Prostate Cancer Disparities in Black Men
Acronym: CoLLab
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07285044
Adenocarcinoma, Adnexal Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT06957691
Adenocarcinoma, Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma
Boston, Massachusetts, United States
View Trial DetailsNCT05438563
Genital Diseases, Genital Diseases, Male
Rochester, Minnesota, United States
View Trial DetailsNCT04857502
Genital Diseases, Genital Diseases, Male
Los Angeles, California, United States
View Trial Details